Macrocyclic fused pyrazoles as Mcl-1 inhibitors
US-12319703-B2 · Jun 3, 2025 · US
Chen Wenming is listed as an inventor on 14 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Chen Wenming |
| Total patents | 14 |
| First publication | Sep 15, 2015 |
| Latest publication | Jun 3, 2025 |
Publications ranked by popularity score, then publication date.
US-12319703-B2 · Jun 3, 2025 · US
US-11691989-B2 · Jul 4, 2023 · US
US-2022396587-A1 · Dec 15, 2022 · US
US-2022388969-A1 · Dec 8, 2022 · US
US-2022340595-A1 · Oct 27, 2022 · US
US-10611748-B2 · Apr 7, 2020 · US
US-2019185444-A1 · Jun 20, 2019 · US
US-9695151-B2 · Jul 4, 2017 · US
US-9695152-B2 · Jul 4, 2017 · US
US-9505742-B2 · Nov 29, 2016 · US
Latest publications not already listed above.
US-2016075687-A1 · Mar 17, 2016 · US
US-2016075686-A1 · Mar 17, 2016 · US
US-2016075688-A1 · Mar 17, 2016 · US
US-9133158-B2 · Sep 15, 2015 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Hoffmann La Roche | 11 |
| Ascentage Pharma Suzhou Co Ltd | 4 |
| Univ Michigan Regents | 4 |
| Ascentage Pharma Group Corp Ltd | 2 |
| Ascentage Pharma Group Corp Ltd | 2 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P9/04 | 7 |
| A61P5/42 | 7 |
| A61P9/12 | 7 |
| A61P13/12 | 7 |
| C07D401/14 | 7 |